These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37328077)

  • 41. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions.
    Morris G; Maes M
    Neuro Endocrinol Lett; 2013; 34(3):185-99. PubMed ID: 23685416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
    Twisk FN
    Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Kerr J
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?
    Kavyani B; Lidbury BA; Schloeffel R; Fisher PR; Missailidis D; Annesley SJ; Dehhaghi M; Heng B; Guillemin GJ
    Cell Mol Life Sci; 2022 Jul; 79(8):412. PubMed ID: 35821534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Yamano E; Watanabe Y; Kataoka Y
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.
    Cook DB; VanRiper S; Dougherty RJ; Lindheimer JB; Falvo MJ; Chen Y; Lin JS; Unger ER;
    PLoS One; 2022; 17(3):e0265315. PubMed ID: 35290404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review.
    Tsamou M; Kremers FAC; Samaritakis KA; Roggen EL
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls.
    Mateo LJ; Chu L; Stevens S; Stevens J; Snell CR; Davenport T; VanNess JM
    Work; 2020; 66(2):265-275. PubMed ID: 32568143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scherbakov N; Szklarski M; Hartwig J; Sotzny F; Lorenz S; Meyer A; Grabowski P; Doehner W; Scheibenbogen C
    ESC Heart Fail; 2020 Jun; 7(3):1064-1071. PubMed ID: 32154656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [History of Researches on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].
    Watanabe Y; Kuratsune H
    Brain Nerve; 2018 Jan; 70(1):5-9. PubMed ID: 29348369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Shimosako N; Kerr JR
    J Clin Pathol; 2014 Dec; 67(12):1078-83. PubMed ID: 25240059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise.
    Giloteaux L; Glass KA; Germain A; Franconi CJ; Zhang S; Hanson MR
    J Extracell Vesicles; 2024 Jan; 13(1):e12403. PubMed ID: 38173127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.